image
Healthcare - Biotechnology - NASDAQ - US
$ 35.94
-2.97 %
$ 2.79 B
Market Cap
-276.46
P/E
INCOME STATEMENT
361 M REVENUE
21.76%
-85.8 M OPERATING INCOME
-108.84%
-74.4 M NET INCOME
-103.51%
EFFICIENCY
Earnings Waterfall Veracyte, Inc.
image
Revenue 361 M
Cost Of Revenue 113 M
Gross Profit 248 M
Operating Expenses 358 M
Operating Income -85.8 M
Other Expenses -11.4 M
Net Income -74.4 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 361.1 296.5 219.5 117.5 120.4 92.0 72.0 65.1 49.5 38.2 21.9 11.6 2.6
GROSS PROFIT
Cost Of Revenue 112.9 101.6 74.4 41.5 36.5 33.1 28.2 25.5 21.5 16.6 12.6 7.6 2.9
Gross Profit 248.1 195.0 145.1 76.0 83.8 58.9 43.8 39.6 28.0 21.6 9.3 4.0 (0.3)
OPERATING INCOME
Operating Expenses 357.9 236.0 227.0 111.4 99.0 81.2 70.3 68.4 61.5 50.6 32.5 23.0 15.0
Selling, General and Administrative Expenses 184.2 174.1 181.2 89.1 82.7 65.3 55.3 52.0 47.9 40.8 24.6 16.4 8.3
Research and Development Expenses 57.3 40.6 29.8 17.2 14.9 14.8 13.9 15.3 12.8 9.8 7.8 6.6 6.7
Operating Income (85.8) (41.1) (81.9) (35.4) (15.1) (22.2) (26.5) (28.8) (33.5) (29.0) (23.2) (18.9) (15.3)
PRE-TAX INCOME
Interest Income Expense 15 K 0.2 0.2 0.2 0.7 2.0 4.9 2.8 0.4 0.4 0.2 0 0
Total Other Income 9.2 4.7 0.3 0.5 2.5 (0.8) (4.5) (2.6) (0.2) (0.4) (2.4) 0.3 0.8
Pre-Tax Income (76.6) (36.4) (81.6) (34.9) (12.6) (23.0) (31.0) (31.4) (33.7) (29.4) (25.6) (18.6) (14.4)
NET INCOME
Tax Provision (2.2) 0.1 (6.1) 0.9 3.9 1.2 5.4 3.0 0.5 (0.7) (2.9) 2 K 0.8
Net Income (74.4) (36.6) (75.6) (35.8) (16.5) (23.0) (31.0) (31.4) (33.7) (29.4) (25.6) (18.6) (14.4)
EPS 1.02 0.51 1.11 0.67 0.36 0.62 0.91 1.09 1.3 1.36 6.15 1.31 1.02